Search

Author/Creator Liu, J.

5. 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results. (December 2022)

Authors:
Cheng, Y.; Wang, J.; Yu, Y.; Zang, A.; Lv, D.; Li, S.; Cao, L.; Meng, Z.; Mao, W.D.; Zhang, J.; Liu, A.; Zhang, Y.; Tang, K.; Liu, J.; Zheng, J.; Wang, Z.; Chen, E.; Zhang, X.; Guo, Q.; Huang, D.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022)

Authors:
Zhao, Y.; Wang, X.; Zhang, M.; Liu, J.; Pu, H.; Li, X.; Zhao, H.; Xu, S.; Yang, M.; Bai, S.; Guo, L.; Zhao, L.; Li, Y.; Wang, Y.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗